Медицинская литература. Новинки

 

 

 

 

 

 

Эффективность маммографического скрининга с оценкой факторов риска рака молочной железы в Республике Индия

Вы можете загрузить полный текст статьи в формате pdf

В работе определено влияние ведущих факторов риска развития рака молочной железы (РМЖ) на эффективность маммографического скрининга. В скрининге РМЖ участвовали 26 912 женщин в 2001–2010 гг. Факторы риска определяли с помощью анкетирования. В рамках скрининга РМЖ всем женщинам выполняли маммографию в прямой и косой проекциях. Для оценки рентгенологической плотности тканей молочной железы использовали шкалу рентгенологической плотности BIRADS. В результате проведенного исследования выявлено, что количество факторов риска развития РМЖ напрямую влияет на стадию заболевания. Установлено, что диагностическая эффективность скрининговой маммографии падает в группах с высокой степенью рентгенологической плотности тканей молочной железы. В работе обосновывается важность контроля групп пациенток с факторами риска РМЖ и целесообразность оценки рентгенологической плотности тканей молочной железы.

Ключевые слова:
рак молочной железы, маммография, скрининг, факторы риска, рентгенологическая плотность тканей молочной железы.

Литература:
1. Hofwind S., Sakshaug S., Ursin G., Graff-Iversen S. Breast
cancer incidence trends in Norway – explained by hormone therapy or mammographic screening? Int. J.
Cancer 2012; 130 (12): 2930–2938.
2. Anderson W.F., Katki H.A., Rosenberg P.S. Incidence of
breast cancer in the United States: current and future
trends. J. Natl. Cancer Inst. 2011; 103 (18): 1397–1402.
3. Kadiyala S., Strumpf E.C. Are United States and Canadian
cancer screening rates consistent with guideline information regarding the age of screening initiation? Int. J. Qual.
Health Care 2011; 23 (6): 611–620.
4. Miller J.W., King J.B., Ryerson A.B. et al. Mammography
Use from 2000 to 2006: State!Level Trends with Corresponding Breast Cancer Incidence Rates. Am. J. Roentgenol 2009; 192: 352–360.
5. Vilaprinyo E., Puig T., Rue M. Contribution of early detection
and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain. PLoS. One 2012; 7 (1): 30157.
6. Park S.K., Kim Y., Kang D. et al. Risk Factors and Control
Strategies for the Rapidly Rising Rate of Breast Cancer
in Korea. J. Breast Cancer 2011; 14 (2): 79–87.
7. Jung K.W., Park S., Kong H.J. et al. Cancer statistics
in Korea: incidence, mortality, survival, and prevalence
in 2008. Cancer Res. Treat. 2011; 43: 1–11.
8. Parkin D.M. The fraction of cancer attributable to lifestyle
and environmental factors in the UK in 2010. Br. J. Cancer
2011; 105 (Suppl. 2): 77–81.
9. Ferlay J., Shin H., Bray F. et al. GLOBOCAN!2008. Cancer
Incidence and mortality worldwide: IARC Cancer Base No.
10. Int. Agency for Research on Cancer. URL:
http://globocan.iarc.fr (дата обращения 26.03.2012).
10. Злокачественные заболевания в России в 2010 году
(заболеваемость и смертность); Под. ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГБУ“МНИОИ им. П.А. Герцена Минздравсоцразвития Рос!
сии”, 2012.
11. Boyle P. Breast cancer control: Signs of progress, but
more work required. Breast 2005; 17: 429–438.
12. Bray F., McCarron P., Parkin D.M. The changing global
patterns of female breast cancer incidence and mortality.
Breast Cancer Res. 2004; 6: 229–239.
13. Abahssain H., Lalya I., M’Rabet F. EL. et al. Breast cancer
in Moroccan young women: a retrospective study. BMC
Res. Notes. 2010; 3: 286.
14. Agarwal G., Pradeep P.V., Aggarwal V. et al. Spectrum of
breast cancer in Asian women. Wld J. Surg. 2007; 31:
1031–1040.
15. Arslan A.A., Formenti S.C. Mammography in developing
countries: the risks associated with globalizing the experiences of the Western world. Nat. Clin. Pract. Oncol. 2009;
6 (3): 136–137.
16. Galukande M., Kiguli!Malwadde E. Rethinking breast cancer screening strategies in resource!limited settings.
African Health Sci. 2010; 10 (1): 89–92.
17. Harford J.B. Breast!cancer early detection in low-income
and middle!income countries: do what you can versus one
size ?ts all. Lancet Oncol. 2011; 12: 306–312.
18. Porter P. “Westernizing” women’s risks? Breast cancer in
lower!income countries. N. Engl. J. Med. 2008; 358 (3):
213–216.
19. Curado M.P., Edwards B., Shin H.R. et al. Cancer incidence in five continents. IX. Lyon: International Agency for
Research on Cancer. 2007; IARC scientific publications
no. 160. URL: http://www.dep.iarc.fr (дата последнего
обращения 18.02.2012).
20. Katoch V.M., Shah B., Nandakumar A. et al. Consolidated
report of hospital based cancer registries 2004–2006.
National Cancer Registry Programme. Bangalore, 2009.
120–126.
21. Shah S., Gala F., Bhatnagar N. Breast cancer in India.
Cancer Patient Aid Association. 2011; URL: http://
www.breastcancerindia.net/bc/statistics/ trends.htm (дата обращения 24.03.2012).
22. Юренева С.В., Коновалова В.Н., Сметник В.П. Заместительная гормонотерапия: дискредитация и реабилитация (обзор литературы). Пробл. репрод. 2009; 2:
74–78.
23. Белилова Н.С., Белилов Ф.И. Факторы риска и профилактика рака. Часть II. Клин. мед. 2005; 12: 20–24.
24. Дмитриев В.Н., Сухотерин И.В., Зыбенко И.И., Дмитриева Т.В. Мутации генов BRCA1, BRCA2 – будущее
предиктивной онкологии: обзор литературы. Опухоли
женской репродукт. сист. 2012; 1: 13–16.
25. American College of Radiology. BI!RADS Breast imaging
reporting and data system. Breast imaging atlas: mammography, breast ultrasound, breast MR!imaging.
Reston, 2003.
26. Kuijpens J.L., Nyklictek I., Louwman M.W. et al.
Hypothyroidism might be related to breast cancer in postmenopausal women. Thyroid 2005; 15 (11): 1253–1259.
27. Hardefeldt P.J., Eslick G.D., Edirimanne S. Benign thyroid
disease is associated with breast cancer: a meta!analysis.
Breast Cancer Res. Treat. 2012; URL: http://
www.ncbi.nlm.nih.gov/pubmed/22434524 (дата обраения 19.03.2012).
28. Ditsch N., Liebhardt S., Von Koch F. et al. Thyroid function
in breast cancer patients. Anticancer Res. 2010; 30:
1713–1717.
29. Angelousi A.G., Anagnostou V.K., Stamatakos M.K. et al.
Primary Hypothyroidism and Risk for Breast Cancer:
A Systematic Review and Meta!Analysis. Eur. J.
Endocrinol. 2012; 166 (3): 373–381.
30. Cristofanilli M., Yamamura Y., Kau S.W. et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is
associated with a reduced incidence of primary breast
carcinoma. Cancer 2005; 103 (6): 1122–1128.
31. Assi V., Warwick J., Cuzick J., Duffy S.W. Clinical and epidemiological issues in mammographic density. Nat. Rev.
Clin. Oncol. 2011; 9 (1): 33–40.
32. Ren B., Smith A.P., Marshall J. Investigation of Practical
Scoring Methods for Breast Density. Lecture Notes in
Computer Science 2010; 6136: 651–658.
33. Weir R., Day P., Ali W. Risk factors for breast cancer in
women. A systematic review of the literature. NZHTA
Report. 2007; 2: 13–28.

Effectiveness of Mammographic Screening with Assessment of Breast Cancer Risk Factors in India

Present article evaluate the influence of leading risk factors established for breast cancer (BC) on the mammography screening efficiency. 26 912 women underwent mammography screening in 2001–2010. BC risk factors were determined by questionnaire. Mammography in mediolateral oblique and craniocaudal projections was performed in all women. BIRADS breast composition categories were used for mammographic breast density evaluation. The direct impact of BC risk factor number on the disease stage was revealed. Diagnostic effectiveness if screening mammography decreased in patient groups with high mammographic density. The importance of control of patient groups with BC risk factors and reasonability of mammographic density evaluation is described.

Keywords:
breast cancer, mammography, screening, risk factors, mammographic density